3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
12
Lung Neoplasms
9
Colorectal Neoplasms
8
Prostatic Neoplasms
7
Pancreatic Neoplasms
3
Ovarian Neoplasms
3
Colonic Neoplasms
3
Skin Carcinoma
2
Melanoma
2
Malignant Solid Neoplasm
2
Lymphoma
2
Hematopoietic and Lymphatic System Neoplasm
2
Hematologic Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Anatomic Stage I Breast Cancer AJCC v8
2
Advanced Malignant Solid Neoplasm
2
Urinary Bladder Neoplasms
1
Triple Negative Breast Neoplasms
1
Spondylitis, Ankylosing
1
Sleep Wake Disorders
1
Rectal Neoplasms
1
Pyloric Stenosis, Hypertrophic
1
Psoriasis
1
Prostate
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Papillomavirus Infections
1
Pain
1
Overweight
1
Obesity-Related Malignant Neoplasm
1
Obesity
1
Interventions
pegaspargase
3
fludarabine phosphate
2
Whole-Body Irradiation
2
Tacrolimus
2
Radiotherapy
2
Peripheral Blood Stem Cell Transplantation
2
Oxaliplatin
2
Mycophenolic Acid
2
Gemcitabine
2
Etoposide
2
Cyclophosphamide
2
Busulfan
2
Asparaginase
2
tislelizumab
1
sugemalimab
1
selinexor
1
pembrolizumab
1
fludarabine
1
Vorinostat
1
Transplantation
1
Tomography, X-Ray Computed
1
Sirolimus
1
Methylprednisolone
1
Methotrexate
1
Melphalan
1
IMC-001
1
Cyclosporine
1
Azacitidine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma, Extranodal NK-T-Cell
×
Early Intervention, Educational
×
90 days
×
Clear all
No trials found.